4 completed. 3 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 3 |
| Phase 2 | 2 | Completed 2 |
Follow NOX-H94: new trials by email Literature Review of NOX-H94 trials Research Report on NOX-H94
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Lexaptepid Pegol (NOX-H94) in ESA-hyporesponsive Anemia in Dialysis Patients Lexaptepid pegol (NOX-H94), Placebo - Anemia, End Stage Renal Disease | Phase 1 / Phase 2 | Completed | TME Pharma AG | 33 | 2014-05-01 | 2015-11-24 |
| Efficacy of NOX-H94 on Anemia of Chronic Disease in Patients With Cancer NOX-H94, Placebo solution - Anemia of Chronic Disease | Phase 2 | Completed | TME Pharma AG | 12 | 2012-09-01 | 2014-06-26 |
| Pharmacokinetics/Pharmacodynamics of NOX-H94 in the Human Endotoxemia Model NOX-H94, Placebo solution - Anemia of Chronic Disease | Phase 1 | Completed | TME Pharma AG | 24 | 2012-01-01 | 2014-11-10 |
| First-in-human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of NOX-H94 NOX-H94, Glucose 5% - Anemia, Chronic Diseases | Phase 1 | Completed | TME Pharma AG | 64 | 2011-07-01 | 2016-01-25 |
Anemia (3) · Chronic Disease (1) · Inflammation (1) · Kidney Failure, Chronic (1) · Lymphoma (1) · Multiple Myeloma (1) · Neoplasms (1)
TME Pharma AG (4)
United Kingdom (2) · Austria (1) · Bulgaria (1) · Germany (1) · Italy (1) · Netherlands (1) · Romania (1)
Kai Riecke, MD (3) · Peter Pickkers, MD, PhD (1) · Riecke Kai, MD (1)